Patients with IBD don’t face an increased risk for major adverse cardiovascular events when taking Janus kinase inhibitors compared with anti-TNF agents.
Carolyn Crist is a freelance journalist specializing in healthcare and human resources topics. Her work has been featured in publications such as Thomson Reuters, HR Drive, Medscape, WebMD, and MDEdge. Carolyn's articles cover a range of issues including work-life balance, cybersecurity, talent retention, healthcare innovations, and social issues impacting the workforce.